| 发明名称 |
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
| 摘要 |
Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy. |
| 申请公布号 |
US9067936(B2) |
申请公布日期 |
2015.06.30 |
| 申请号 |
US201214237905 |
申请日期 |
2012.08.15 |
| 申请人 |
GlaxoSmithKline LLC |
发明人 |
Demont Emmanuel Hubert;Jones Katherine Louise;Watson Robert J. |
| 分类号 |
C07D471/00;A61K31/44;C07D471/04;A61K31/4745 |
主分类号 |
C07D471/00 |
| 代理机构 |
|
代理人 |
Brink Robert H. |
| 主权项 |
1. A compound of formula (I) which is 4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazoleor a salt thereof. |
| 地址 |
Wilmington DE US |
